The Type 2 diabetes drug Victoza may be associated with an increased risk of pancreatic cancer. A devastating disease, 95% of those diagnosed with pancreatic cancer will survive less than five years.
Victoza users who were diagnosed with pancreatic cancer, as well as their surviving family members, may be entitled to compensation for their pain and suffering. To learn more about filing a Victoza lawsuit, please contact the nationwide law firm of Bernstein Liebhard LLP at (888) 994-5118.
Victoza belongs to a class of Type 2 diabetes drugs called incretin mimetics. Some studies have suggested that medications in this class may increase a patient’s risk for pancreatic cancer.
In March 2013, the FDA announced that it was investigating the entire incretin mimetics class, following the publication of the study in Diabetes that same month. However, the agency has so far been unable to confirm a link between these drugs and pancreatic cancer
The pancreas is a digestive organ that produces insulin and glucagon, two metabolic hormones that are involved in regulating blood glucose. The pancreas also produces digestive enzymes that help break down food.
Pancreatic cancer usually spreads rapidly and is rarely detected in its early stages, as the majority of patients do not experience any symptoms early on. In fact, symptoms may not appear until the disease is very advanced, and sugery is no longer an option.
Signs and symptoms of pancreatic cancer may include:
You may be entitled to compensation if you or a loved one were diagnosed with pancreatic cancer while using Victoza. To learn how the attorneys at Bernstein Liebhard LLP can help you pursue a Victoza lawsuit, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.